{"name":"Dienogest","slug":"dienogest","kind":"substance","abbreviations":["DNG"],"systematic":null,"aliases":["Dienogestril","Dienogestum","Endometrion","Sts 557","Sts-557","Mjr-35","17α-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile","Zk 37659","M 18575","M-18575"],"brands":["Visanne"],"scraped":true,"has_structure":true,"cid":68861,"classes":[],"families":[],"physical":[{"label":"Molecular mass","value":"311.40 g/mol","copyable":false},{"label":"Melting point","value":"210-218","copyable":false},{"label":"Solubility","value":"Practically insoluble","copyable":false},{"label":"Predicted LogP","value":"1.8","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>20</sub>H<sub>25</sub>NO<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile","copyable":true},{"label":"SMILES","value":"C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC#N)O","copyable":true},{"label":"InChI","value":"InChI=1S/C20H25NO2/c1-19-8-6-16-15-5-3-14(22)12-13(15)2-4-17(16)18(19)7-9-20(19,23)10-11-21/h12,17-18,23H,2-10H2,1H3/t17-,18+,19+,20-/m1/s1","copyable":true},{"label":"InChIKey","value":"AZFLJNIPTRTECV-FUMNGEBKSA-N","copyable":true},{"label":"CAS number","value":"65928-58-7","copyable":true},{"label":"UNII","value":"46M3EV8HHE","copyable":true},{"label":"PubChem CID","value":"68861","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"7.5–10.7 hours","copyable":false},{"label":"Metabolism","value":"Liver (reduction, hydroxylation via CYP3A4, removal of cyanomethyl group, conjugation)<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false},{"label":"Excretion","value":"Urine<a href=\"#cite_note-4\"><sup>[4]</sup></a>","copyable":false},{"label":"Routes of administration","value":"By mouth","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"G","description":"Genito urinary system and sex hormones"},{"code":"G03","description":"Sex hormones and modulators of the genital system"},{"code":"G03D","description":"Progestogens"},{"code":"G03DB","description":"Pregnadien derivatives"},{"code":"G03DB08","description":""},{"code":"G03DB08","description":"Dienogest"}],"mesh":[{"name":"Contraceptive Agents, Male","id":"M0005104"},{"name":"Contraceptives, Oral, Hormonal","id":"M0005118"},{"name":"Hormone Antagonists","id":"M0010537"},{"name":"Antineoplastic Agents, Hormonal","id":"M0028300"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"CYP3A4","mechanisms":["metabolism","inhibition","induction"],"partners":230,"contraindicated":0},{"target":"PGR","mechanisms":["shared target"],"partners":37,"contraindicated":1}],"mechanism":"Dienogest acts as an agonist at the progesterone receptor (PR) with weak affinity that is comparable to that of progesterone but has a very potent progestagenic effect in the endometrium, causing endometrial atrophy after prolonged use. It promotes antiproliferative, immunologic and antiangiogenic effects on endometrial tissue. Dienogest reduces the level of endogenous production of oestradiol and thereby suppressing the trophic effects of oestradiol on both the eutopic and ectopic endometrium. Continous administration of dienogest results in hyperprogestogenic and moderately hypoestrogenic endocrine environment, which causes initial decidualization of endometrial tissue.  It is an antagonist at androgen receptors, improve androgenic symptoms such as acne and hirsutism.","side_effects":null,"effects":null,"usernotes":[{"user":"emily","user_slug":"emily","external":false,"note":{"substance":"Dienogest","composite":false,"routes":[{"name":"oral","dosage":"2mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}},{"user":"Pilz","user_slug":"pilz","external":false,"note":{"substance":"Dienogest","composite":false,"routes":[{"name":"oral","dosage":"2mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":["Might be useful as an {wkp 'Antiandrogen'}"]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Dienogest"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/68861"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q139160"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB09123"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1201864"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A70708"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=65928-58-7"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D03799"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID80891478"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Dienogest"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/46M3EV8HHE"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 68861, Dienogest. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/68861>https://pubchem.ncbi.nlm.nih.gov/compound/68861</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Dienogest. UNII: 46M3EV8HHE. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/46M3EV8HHE>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/46M3EV8HHE</a>","Stanczyk FZ. All progestins are not created equal. Steroids. November 2003; 68(10–13):879–890. PMID 14667980. <a href='https://doi.org/10.1016/j.steroids.2003.08.003'>https://doi.org/10.1016/j.steroids.2003.08.003</a>","Bizzarri N, Remorgida V, Leone Roberti Maggiore U, Scala C, Tafi E, Ghirardi V, Salvatore S, Candiani M, Venturini PL, Ferrero S. Dienogest in the treatment of endometriosis. Expert Opinion on Pharmacotherapy. September 2014; 15(13):1889–1902. PMID 25069386. <a href='https://doi.org/10.1517/14656566.2014.943734'>https://doi.org/10.1517/14656566.2014.943734</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 11:03:25","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 11:03:21","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 11:03:21","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 11:03:21","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 11:03:21","note":"no HMDB id"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 11:03:24","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 11:03:21","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 11:03:21","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 11:03:21","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 11:03:21","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 11:03:21","note":null}],"description":"Dienogest is a  substance."}